Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis
- 10 August 2006
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 26 (6) , 1237-1254
- https://doi.org/10.1002/sim.2624
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Therapeutic Strategies for Rheumatoid ArthritisNew England Journal of Medicine, 2004
- New Drugs for Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003
- ReplyArthritis & Rheumatism, 2002
- Network meta‐analysis for indirect treatment comparisonsStatistics in Medicine, 2002
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002
- Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- Etanercept Therapy in Rheumatoid ArthritisAnnals of Internal Medicine, 1999
- Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonistArthritis & Rheumatism, 1998